Skip to content

Pedal Pump and Leg Lymphedema

Effectiveness of the Osteopathic Pedal Pump in Reducing Lower Limb Volume in Older Adults with Chronic Leg Lymphedema

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06235463
Enrollment
72
Registered
2024-02-01
Start date
2024-04-09
Completion date
2025-11-08
Last updated
2024-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lymphedema

Brief summary

Chronic lymphedema in the lower extremities is a common problem found in older adults that can result in cellulitis, poor wound healing, venous stasis ulcers, and other comorbidities. Compressive therapies are the present gold standard for the manual treatment of lymphedema in the lower extremities. However, the benefits of these compressive therapies are modest, and they are not well tolerated by older adults. An alternative manual treatment is the osteopathic pedal pump, an osteopathic manipulative treatment, that uses a rhythmical pumping motion instead of compressive force to move interstitial fluid from the lower extremities back to the circulatory system. However, the evidence that the osteopathic pedal pump can reduce volume in the lower extremities remains anecdotal. The aim of this study is to determine if the osteopathic pedal pump can reduce volume in the lower extremities among older adults with chronic lymphedema. Leg volume will be measured using water displacement. Older adults with chronic lymphedema of the lower extremities will be randomly assigned to one of two groups: a treatment group that will receive one session of the osteopathic pedal pump and a control group that will receive one session of a light touch treatment.

Interventions

OTHEROsteopathic Pedal Pump

Participants randomized to this condition will receive 5 minutes of myofascial release to the thoracic inlet and 5 minutes of the pedal pump technique.

OTHERLight Touch Treatment

Participants randomized to receive the sham treatment will receive light touch from the operator on the base of the neck and the balls of the feet. This light touch is meant to mimic the pedal pump through touching the same areas of the body but without palpating so that no lymphatic fluid is removed from the lower limbs.

Sponsors

Rowan University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Masking description

The investigator who will be responsible for carrying out the measurements of lower limb volume via water displacement will be blinded to the condition each participant is randomized to. Withholding this information from the investigator conducing the measurements will prevent this information from influencing how the measurements are conducted and therefore removing bias that could skew the results in support of the study's hypotheses (i.e., that the pedal pump does reduce lower limb volume in older adults with lower extremity lymphedema).

Intervention model description

Fifty two participants will be randomized to one of two conditions: to receive the osteopathic pedal pump (treatment group) or to receive a light tough treatment (control group).

Eligibility

Sex/Gender
ALL
Age
55 Years to 100 Years
Healthy volunteers
Yes

Inclusion criteria

* Age 55 years old or older * Have lower leg lymphedema

Exclusion criteria

* Any type of acute medical issue or exacerbation * A chronic medical condition (e.g., asthma, chronic obstructive pulmonary disease, congestive heart failure) * An active tissue infection or an open wound in the lower limb * An active bone fracture * Acute deep venous thrombosis not fully anticoagulated * Dementia

Design outcomes

Primary

MeasureTime frameDescription
Change in limb volumeThe time frame in which the pre and post-treatment measurements will take place in one session that will take approximately 30-45 minutes.Difference in lower limb volume, as measured by water displacement, from pre to post-treatment.

Countries

United States

Contacts

Primary ContactMatt McLaughlin
mclaugmh@rowan.edu(856) 566-6330

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026